Your browser doesn't support javascript.
loading
Monitoring the impact of COVID-19 in France on cancer care: a differentiated impact.
Le Bihan Benjamin, Christine; Simonnet, Julien-Aymeric; Rocchi, Mathieu; Khati, Inès; Ménard, Estelle; Houas-Bernat, Emilie; Méric, Jean-Baptiste; Bousquet, Philippe-Jean.
Afiliação
  • Le Bihan Benjamin C; Health Data and Assessment Department, Survey Data Science and Assessment Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
  • Simonnet JA; Care Paths Organization Department, Public Health Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
  • Rocchi M; Health Data and Assessment Department, Survey Data Science and Assessment Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
  • Khati I; Health Data and Assessment Department, Survey Data Science and Assessment Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
  • Ménard E; Survey Data Science and Assessment Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
  • Houas-Bernat E; Care Paths Organization Department, Public Health Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
  • Méric JB; Public Health Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France.
  • Bousquet PJ; Survey Data Science and Assessment Division, National Cancer Institute, 52 Avenue André Morizet, 92100, Boulogne-Billancourt, France. pjbousquet@institutcancer.fr.
Sci Rep ; 12(1): 4207, 2022 03 10.
Article em En | MEDLINE | ID: mdl-35273304
The COVID-19 pandemic has had a substantial and lasting impact on care provision, particularly in the field of cancer care. National steering has helped monitor the health situation and adapt the provision and organisation of care. Based on data from the French administrative healthcare database (SNDS) on the entire French population (67 million people), screening, diagnostic and therapeutic activity was monitored and compared 2019 on a monthly basis. A noteworthy decline in all activities (with the exception of chemotherapy) was observed during the first lockdown in France. Over the months that followed, this activity returned to normal but did not make up for the shortfall from the first lockdown. Finally, during the lockdown in late 2020, cancer care activity was conserved. In brief, in 2020, the number of mammograms decreased by 10% (- 492,500 procedures), digestive endoscopies by 19% (- 648,500), and cancer-related excision by 6% (- 23,000 surgical procedures). Hospital radiotherapy activity was down 3.8% (- 4400 patients) and that in private practice was down 1.4% (- 1600 patients). Chemotherapy activity increased by 2.2% (7200 patients), however. To summarize, COVID-19 had a very substantial impact during the first lockdown. Safeguarding cancer care activity helped limit this impact over the months that followed, but the situation remains uncertain. Further studies on the medium- and long-term impact on individuals (survival, recurrence, after-effects) will be conducted.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quarentena / Serviço Hospitalar de Oncologia / Atenção à Saúde / COVID-19 / Neoplasias Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quarentena / Serviço Hospitalar de Oncologia / Atenção à Saúde / COVID-19 / Neoplasias Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França